Regulation of cytochrome P450 (CYP) genes by nuclear receptors

Biochemical Journal

Volumn 347, Issue 2, 2000, Pages 321-337

  Honkakoski, Paavo ^a   Negishi, Masahiko ^b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Endobiotic metabolism; Gene expression; Gene transcription; Ligand activated; Xenobiotic metabolism

Indexed keywords

CELL NUCLEUS RECEPTOR; CYTOCHROME P450 3A; CYTOCHROME P450 ISOENZYME; ESTROGEN RECEPTOR; FATTY ACID; GLUCOCORTICOID RECEPTOR; ISOPROTEIN; POLYCYCLIC HYDROCARBON; RETINOID BINDING PROTEIN; SCATTER FACTOR; STEROID;

CARCINOGENESIS; DNA RESPONSIVE ELEMENT; ENDOCRINE SYSTEM; ENZYME ACTIVITY; FATTY ACID METABOLISM; GENE ACTIVATION; GENE CONTROL; HOMEOSTASIS; HUMAN; LIGAND BINDING; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; SEX DIFFERENCE; STEROID METABOLISM;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; DIMERIZATION; FEEDBACK; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; ISOENZYMES; LIGANDS; RECEPTOR CROSS-TALK; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RESPONSE ELEMENTS; SEX DETERMINATION (GENETICS);

STAPHYLOCOCCUS PHAGE 3A;

EID: 0034655747     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/0264-6021:3470321     Document Type: Review

References (303)

1. 1 Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W. et al. (1996) P450 superfamily: update on new sequences, gene mapping, accession numbers, and nomenclature. Pharmacogenetics 6, 1-42
2. 2 Nelson, D. R. (1999) Cytochrome P450 and the individuality of species. Arch. Biochem. Biophys. 369, 1-10
3. 3 Negishi, M., Uno, T., Darden, T. A., Sueyoshi, T. and Pedersen, L. P. (1996) Structural flexibility and functional versatility of mammalian P450 enzymes. FASEB J. 10, 663-689
4. 4 Peterson, J. A. and Graham, S.E. (1998) A close family resemblance: the importance of structure in understanding cytochromes P450. Structure 6, 1079-1085
5. 5 Guengerich, F. P. (1997) Comparisons of catalytic selectivity of cytochrome P450 subfamily enzymes from different species. Chem.-Biol. Interact. 106, 161-182
6. 6 Rendic, S. and DiCarlo, F. J. (1997) Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metab. Rev. 29, 413-580
7. 7 Waxman, D. J. and Azaroff, L. (1992) Phenobarbital induction of cytochrome P450 gene expression. Biochem. J. 281, 577-592
8. 8 Denison, M. S. and Whitlock, J. P. (1995) Xenobiotic-inducible transcription of cytochrome P450 genes. J. Biol. Chem 270, 18175-18178
9. 9 Waxman, D. J. (1999) P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR. Arch. Biochem. Biophys. 369, 11-23
10. 10 Meyer, U. A. and Zanger, U. M. (1997) Molecular mechanisms of genetic polymorphisms of drug metabolism. Annu. Rev. Pharmacol. Toxicol. 37, 269-296
11. 11 Taningher, M., Malacarne, D., Izzotti, A., Ugotini, D. and Parodi, S. (1999) Drug metabolism polymorphisms as modulators of cancer susceptibility. Mutat. Res. 436, 227-261
12. 12 Waxman, D. J. (1988) Interactions of hepatic cytochromes P450 with steroid hormones. Biochem. Pharmacol. 37, 71-84
13. 13 Rifkind, A. B., Lee, C., Chang, T. K. and Waxman, D. J. (1995) Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic epoxygenation in human liver microsomes. Arch. Biochem. Biophys. 320, 380-389
14. 14 Duester, G. (1996) Involvement of alcohol dehydrogenase, short chain dehydrogenase/reductase, aldehyde dehydrogenase, and cytochrome P450 in the control of retinoid signaling by activation of retinoic acid synthesis. Biochemistry 35, 12221-12227
15. 15 Harder, D. R., Campbell, W. B. and Roman, R. J. (1995) Role of cytochrome P450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J. Vasc. Res. 32, 79-82
16. 16 Waxman, D. J. and Chang, T. K. H. (1995) Hormonal regulation of liver cytochrome P450 enzymes. In Cytochrome P450: Structure, Mechanism, and Biochemistry, 2nd edn. (Ortiz de Montellano, P. R., ed.), pp. 391-417, Plenum Press, New York
17. 17 Nebert, D. W. (1991) Proposed role of drug-metabolizing enzymes: regulation of steady state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine functions. Mol. Endocrinol. 5, 1203-1214
18. 18 Andreola, F., Fernandez-Salguero, P. M., Chiantore, M. V., Petkovich, M. P., Gonzalez, F. J. and De Luca, L. M. (1997) Aryl hydrocarbon receptor knockout mice (AhR - / - ) exhibit liver retinoid accumulation and reduced retinoic acid metabolism. Cancer Res. 57, 2835-2838
19. 19 Plasilova, M., Stoilov, I., Sarfarasi, M., Kadasi, L., Ferakova, E. and Ferak, V. (1999) Identification of a single ancestral CYP1B1 mutation in Slovak gypsies (Rom) affected with primary congenital glaucoma. J. Med. Genet. 36, 290-294
20. 20 Keeney, D. S. and Waterman, M. R. (1993) Regulation of steroid hydroxylase gene expression: importance to physiology and disease. Pharmacol. Ther. 58, 301-317
21. 21 Jones, G., Strugnell, S. A. and DeLuca, H. F. (1998) Current understanding of the molecular actions of vitamin D. Physiol. Rev. 78, 1193-1231
22. 22 White, P. C. (1994) Genetic diseases of steroid metabolism. Vitam. Horm. 49, 131-195
23. 23 Setchell, K. D. R., Schwarz, M., O'Connell, N. C., Lund, E. G., Davis, D. L., Lathe, R., Thompson, H. R., Tyson, R. W., Sokol, R. J. and Russell, D. W. (1998) Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7α-hydroxylase gene causes severe neonatal liver disease. J. Clin. Invest. 102, 1690-1703
24. 24 Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P. and Evans, R. M. (1995) The nuclear receptor superfamily: the second decade. Cell 83, 835-839
25. 25 Kastner, P., Mark, M. and Chambon, P. (1995) Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell 83, 859-869
26. 26 Enmark, E. and Gustafsson, J.-Å. (1996) Orphan nuclear receptors - the first eight years. Mol. Endocrinol. 10, 1293-1307
27. 27 Nuclear Receptors Nomenclature Committee (1999) A unified nomenclature system for the nuclear receptor superfamily. Cell 97, 161-163
28. 28 Forrest, D., Golarai, G., Connor, J. and Curran, T. (1996) Genetic analysis of thyroid hormone receptors in development and disease. Recent Prog. Horm. Res. 51, 1-22
29. 29 Minucci, S. and Pelicci, P. G. (1999) Retinoid receptors in health and disease: coregulators and the chromatin connection. Semin. Cell Dev. Biol. 10, 215-225
30. 30 Yong, E. L., Tut, T. G., Ghadessy, F. J., Prins, G. and Ratnam, S. S. (1998) Partial androgen insensitivity and correlations with the predicted three dimensional structure of the androgen receptor ligand-binding domain. Mol. Cell. Endocrinol. 137, 41-50
31. 31 Mangelsdorf, D. J. and Evans, R. M. (1995) The RXR heterodimers and orphan receptors. Cell 83, 841-850
32. 32 Wilson, T. E., Mouw, A. R., Weaver, C. A., Milbrandt, J. and Parker, K. L. (1993) The orphan nuclear receptor NGFI-B regulates expression of the gene encoding steroid 21-hydroxylase. Mol. Cell. Biol. 13, 861-868
33. 33 Willy, P., Umesono, K., Ong, E. S., Evans, R. M., Heyman, R. A. and Mangelsdorf, D. J. (1995) LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev. 9, 1033-1045
34. 34 Juge-Aubry, C., Pernin, A., Favez, T., Burger, A. G., Wahli, W., Meier, C. A. and Desvergne, B. (1997) DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. J. Biol. Chem. 272, 25252-25259
35. 35 Rastinejad, F., Perlmann, T., Evans, R. M. and Sigler, P. B. (1995) Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature (London) 375, 203-211
36. 36 Meinke, G. and Sigler, P. B. (1999) DNA-binding mechanism of the monomeric orphan nuclear receptor NGFI-B. Nat. Struct. Biol. 6, 471-477
37. 37 Hsu, M. H., Palmer, C. N., Song, W., Griffin, K. J. and Johnson, E. F. (1998) A carboxyl-terminal extension of the zinc finger domain contributes to the specificity and polarity of peroxisome proliferator-activated receptor DNA binding. J. Biol. Chem. 273, 27988-27997
38. 38 Zechel, C., Shen, X. Q., Chambon, P. and Gronemeyer, H. (1994) The dimerization interfaces formed between the DNA binding domains of RXR, RAR, and TR determine the binding specificity and polarity of the full-length receptors to direct repeats. EMBO J. 13, 1414-1424
39. 39 Perlmann, T., Umesono, K., Rangarajan, P. N., Forman, B. M. and Evans, R. M. (1996) Two distinct dimerization interfaces differentially modulate target gene specificity of nuclear hormone receptors. Mol. Endocrinol. 10, 958-966
40. 40 Tanenbaum, D. M., Wang, Y., Williams, S. P. and Sigler, P. B. (1998) Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc. Natl. Acad. Sci. U.S.A. 95, 5998-6003
41. 41 Moras, D. and Gronemeyer, H. (1998) The nuclear receptor ligand-binding domain: structure and function. Curr. Opin. Cell Biol. 10, 384-391
42. 42 Wagner, R. L., Apriletti, J. W., McGrath, M. E., West, B. L., Baxter, J. D. and Fletterick, R. J. (1995) A structural role for hormone in the thyroid hormone receptor. Nature (London) 378, 690-697
43. 43 Brzozowski, A. M., Pike, A. C. W., Dauter, Z., Hubbard, R. E., Bonn, T., Engström, O., Öhman, L., Greene, G. L., Gustafsson, J.-Å. and Carlquist, M. (1997) Molecular basis of agonism and antagonism in the oestrogen receptor. Nature (London) 389, 753-758
44. 44 Nolte, R. T., Wisely, G. B., Westin, S., Cobb, J. E., Lambert, M. H., Kurokawa, R., Rosenfeld, M. G., Willson, T. M., Glass, C. K. and Milburn, M. V. (1998) Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ. Nature (London) 395, 137-143
45. 45 Glass, C. K., Rose, D. W. and Rosenfeld, M. G. (1997) Nuclear receptor coactivators. Curr. Opin. Cell Biol. 9, 222-232
46. 46 Xu, L., Glass, C. K. and Rosenfeld, M. G. (1999) Coactivator and corepressor complexes in nuclear receptor function. Curr. Opin. Genet. Dev. 9, 140-147
47. 47 Darimont, B. D., Wagner, R. L., Apriletti, J. W., Stallcup, M. R., Kushner, P. J., Baxter, J. D., Fletterick, R. J. and Yamamoto, K. R. (1998) Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 12, 3343-3356
48. 48 Grant, P. A. and Berger, S. L. (1999) Histone acetyltransferase complexes. Semin. Cell Dev. Biol. 10, 169-177
49. 49 Johnson, C. A. and Turner, B. M. (1999) Histone deacetylases: complex transducers of nuclear signals. Semin. Cell Dev. Biol. 10, 179-188
50. 50 Shao, D., Rangwala, S. M., Bailey, S. T., Krakow, S. L. Reginato, M. J. and Lazar, M. A. (1998) Interdomain communication regulating ligand binding by PPAR-γ. Nature (London) 396, 377-380
51. 51 Hammer, G. D., Krylova, I., Zhang, Y., Darimont, B. D., Simpson, K., Weigel, N. L. and Ingraham, H. A. (1999) Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of the hormone signaling in reproduction and stress. Mol. Cell 3, 521-526
52. 52 Crofts, L. A., Hancock, M. S., Morrison, N. A. and Eisman, J. A. (1998) Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor gene transcripts. Proc. Natl. Acad. Sci. U.S.A. 95, 10529-10534
53. 53 Fasco, M. J. (1998) Estrogen receptor mRNA splice variants produced from the distal and proximal promoter transcripts. Mol. Cell. Endocrinol 138, 51-59
54. 54 Guiochon-Mantel, A., Delabre, K., Lescop, P. and Milgrom, E. (1996) Intracellular traffic of steroid hormone receptors. J. Steroid Biochem Mol. Biol. 56, 1-6
55. 55 Zhu, X.-G., Hanover, J. A., Hager, G. L. and Cheng, S. (1998) Hormone-induced translocation of thyroid hormone receptors in living cells using a green fluorescent protein chimera. J. Biol. Chem. 273, 27058-27063
56. 56 Weigel, N. L. (1996) Steroid hormone receptors and their regulation by phosphorylation. Biochem. J. 319, 657-667
57. 57 Shao, D. and Lazar, M. A. (1998) Modulating nuclear receptor function: may the phos be with you. J. Clin. Invest. 103, 1617-1618
58. 58 Kim, J. H., Stansbury, K. H., Walker, N. J., Trush, M. A., Strickland, P. T. and Sutter, T. R. (1998) Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1. Carcinogenesis 19, 1847-1853
59. 59 Martucci, C. P. and Fishman, J. (1993) P450 enzymes of estrogen metabolism. Pharmacol. Ther. 57, 237-257
60. 60 Hayes, C. L., Spink, D. C., Spink, B. C., Cao, J. Q., Walker, N. J. and Sutter, T. R. (1996) 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc. Natl. Acad. Sci. U.S.A. 93, 9776-9781
61. 61 Hankinson, O. (1995) The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 35, 307-340
62. 62 Chen, Y. H. and Tukey, R. H. (1996) Protein kinase C modulates regulation of the CYP1A1 gene by the aryl hydrocarbon receptor. J. Biol. Chem. 271, 26261-26266
63. 63 Carrier, F., Owens, R. A., Nebert, D. W. and Puga, A. (1992) Dioxin-dependent activation of murine Cyp1a-1 gene transcription requires protein kinase C-dependent phosphorylation. Mol. Cell Biol. 12, 1856-1863
64. 64 Mathis, J. M., Prough, R. A., Hines, R. N., Bresnick, E. and Simpson, E. R. (1986) Regulation of cytochrome P450c by glucocorticoids and polycyclic aromatic hydrocarbons in cultured fetal rat hepatocytes. Arch. Biochem. Biophys. 246, 439-448
65. 65 Sidhu, J. S. and Omiecinski, C. J. (1995) Modulation of xenobiotic-inducible cytochrome P450 gene expression by dexamethasone in primary rat hepatocytes. Pharmacogenetics 5, 24-36
66. 66 Celander, M., Weisbrod, R. and Stegeman, J. J. (1997) Glucocorticoid potentiation of cytochrome P4501A1 induction by 2,3,7,8-tetrachlorodibenzo-ρ-dioxin in porcine and human endothelial cells in culture. Biochem. Biophys. Res. Commun. 232, 749-753
67. 67 Sherratt, A. J., Banet, D. E., Linder, M. W. and Prough, R. A. (1989) Potentiation of 3-methylcholanthrene induction of cytochrome P450IA1 by dexamethasone in vivo. J. Pharmacol. Exp. Ther. 249, 667-672
68. 68 Mathis, J. M., Houser, W. H., Bresnick, E., Cidlowski, J. A., Hines, R. N., Prough, R. A. and Simpson, E. R. (1989) Glucocorticoid receptor regulation of the rat cytochrome P450c (P450IA1) gene: receptor binding within intron I. Arch. Biochem. Biophys. 269, 93-105
69. 69 Linder, M. W., Falkner, K. C., Srinivasan, G , Hines, R. N. and Prough, R. A. (1999) Role of canonical glucocorticoid responsive elements in modulating expression of genes regulated by the arylhydrocarbon receptor. Drug Metab. Rev. 31, 247-271
70. 70 Brake, P. B., Zhang, L. and Jefcoate, C. R. (1998) Aryl hydrocarbon receptor regulation of cytochrome P4501B1 in rat mammary fibroblasts: evidence for transcriptional repression by glucocorticoids Mol. Pharmacol. 54, 825-833
71. 71 König, H., Ponta, H., Rahmsdorf, H. J. and Herrlich, P. (1992) Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J. 11, 2241-2246
72. 72 Thomsen, J. S , Wang, X., Hines, R. N. and Safe, S. (1994) Restoration of aryl hydrocarbon (Ah) responsiveness in MDA-MB-231 human breast cancer cells by transient expression of the estrogen receptor. Carcinogenesis 15, 933-937
73. 73 Spink, B. C., Fasco, M. J., Gierthy, J. F. and Spink, D. C. (1998) 12-O-tetra-decanoylphorbol 13-acetate upregulates the Ah receptor and differentially alters CYP1B1 and CYP1A1 expression in MCF-7 breast cancer cells. J. Cell. Biochem. 70, 289-296
74. 74 Jana, N. R., Sarkar, S., Ishizuka, M., Yonemoto, J., Tohyama, C. and Sone, H. (1999) Role of estrogen receptor-α in differential expression of 2,3,7,8-tetrachlorodibenzo-ρ-dioxin-inducible genes in the RL95-2 and KLE human endometrial cancer cell lines. Arch. Biochem. Biophys. 368, 31-39
75. 75 Angus, W G., Larsen, M. C. and Jefcoate, C. R. (1999) Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status. Carcinogenesis 20, 947-955
76. 76 Ignar-Trowbridge, D. M., Nelson, K. G., Bidwell, M. C., Curtis, S. W., Washburn, T. F., McLachlan, J. A. and Korach, K. S. (1992) Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc. Natl. Acad. Sci. U.S.A. 89, 4658-4662
77. 77 Bunone, G., Briand, P.-A., Miksicek, R. J. and Picard, D. (1996) Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J. 15, 2174-2183
78. 78 Korach, K. S., Couse, J. F., Curtis, S. W., Washburn, T. D , Lindzey, J., Kimbro, K. S., Eddy, E. M., Migliaccio, S., Snedeker, S. M., Lubahn, D. B. et al. (1996) Estrogen receptor gene disruption, molecular characterization and experimental and clinical phenotypes. Recent Prog. Horm. Res. 51, 159-186
79. 79 Kharat, I. and Saatcioglu, F. (1996) Antiestrogenic effects of 2,3,7,8-tetrachlorodibenzo-ρ-dioxin are mediated by direct interference with the liganded estrogen receptor. Crosstalk between aryl hydrocarbon- and estrogen-mediated signaling. J. Biol. Chem 271, 10533-10537
80. 80 Hoivik, D., Willett, K., Wilson, C. and Safe, S. (1997) Estrogen does not inhibit 2,3,7,8-tetrachlorodibenzo-ρ-dioxin-mediated effects in MCF-7 and Hepa 1c1c7 cells. J. Biol. Chem. 272, 30270-30274
81. 81 Ricci, M. S., Toscano, D. G., Mattingly, C. J. and Toscano, Jr., W. A. (1999) Estrogen receptor reduces CYP1A1 induction in cultured human endometrial cells. J. Biol. Chem. 274, 3430-3438
82. 82 Kumar, M. B., Tarpey, R. W. and Perdew, G. H. (1999) Differential recruitment of coactivator RIP140 by Ah and estrogen receptors. Absence of a role tor LXXLL motifs. J. Biol. Chem. 274, 22155-22164
83. 83 Nguyen, T. A., Hoivik, D., Lee, J. E. and Safe, S. (1999) Interactions of nuclear receptor coactivator/corepressor proteins with the aryl hydrocarbon receptor complex. Arch. Biochem. Biophys. 367, 250-257
84. 84 Mäkelä, S., Savolainen, H., Aavik, E., Myllärniemi, M., Strauss, L., Taskinen, E., Gustafsson, J.-Å. and Häyry, P. (1999) Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors a and β. Proc. Natl. Acad. Sci. U.S.A. 96, 7077-7082
85. 85 Vanacker, J. M., Pettersson, K., Gustafsson, J.-Å and Laudet, V. (1999) Transcriptional targets shared by estrogen receptor-related receptors (ERRs) and estrogen receptor (ER) α, but not by ERβ. EMBO J. 18, 4270-4279
86. 86 Vanacker, J. M., Bonnelye, E., Chopin-Delannoy, S., Delmarre, C., Cavailles, V. and Laudet, V. (1999) Transcriptional activities of the orphan nuclear receptor ERRα (estrogen receptor-related receptor α). Mol. Endocrinol. 13, 764-773
87. 87 Li, X-Y., Åstrom, A., Duell, E. A., Qin, L., Griffiths, C. E. and Voorhees, J. J. (1995) Retinoic acid antagonizes basal as well as coal tar- and glucocorticoid-induced cytochrome P450 1A1 expression in human skin. Carcinogenesis 16, 519-525
88. 88 Wanner, R., Brommer, S., Czarnetzki, B. M. and Rosenbach, T. (1995) The differentiation-related upregulation of aryl hydrocarbon receptor transcript levels is suppressed by retinoic acid. Biochem. Biophys. Res. Commun. 209, 706-711
89. 89 Vecchini, F., Mace, K., Magdalou, J., Mahe, Y., Bernard, B. A. and Shroot, B. (1995) Constitutive and inducible expression of drug metabolizing enzymes in cultured human keratinocytes. Br. J. Dermatol 132, 14-21
90. 90 Vecchini F., Lenoir-Viale, M. C., Cathelineau, C., Magdalou, J., Bernard, B. A. and Shroot, B. (1994) Presence of a retinoid responsive element in the promoter region of the human cytochrome P4501A1 gene. Biochem. Biophys. Res. Commun. 201, 1205-1212
91. 91 Jurima-Romet, M., Neigh, S. and Casley, W. L. (1997) Induction of cytochrome P4503A by retinoids in rat hepatocyte culture. Hum. Exp. Toxicol. 16, 198-203
92. 92 Howell, S. R., Shirley, M. A. and Ulm, E. H. (1998) Effects of retinoid treatment of rats on hepatic microsomal metabolism and cytochromes P450. Correlation between retinoic acid receptor/retinoid X receptor selectivity and effects on metabolic enzymes. Drug Metab. Dispos. 26, 234-239
93. 93 Safe, S., Wang, F., Porter, W., Duan, R. and McDougal, A. (1998) Ah receptor agonists as endocrine disruptors: antiestrogenic activity and mechanisms. Toxicol. Lett. 102-103, 343-347
94. 94 Krishnan, V., Porter, W., Santostefano, M , Wang, X. and Safe, S. (1995) Molecular mechanism of inhibition of estrogen-induced catriepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-ρ-dioxin (TCDD) in MCF-7 cells. Mol. Cell. Biol. 15, 6710-6719
95. 95 Wang, X., Porter, W., Krishnan, V , Narasimhan, T. R. and Safe, S. (1993) Mechanism of 2,3,7,8-tetrachlorodibenzo-ρ-dioxin (TCDD)-mediated decrease of the nuclear estrogen receptor in MCF-7 human breast cancer cells. Mol. Cell. Endocrinol. 96, 159-166
96. 96 Gierthy, J. F., Spink, B. C., Figge, H. L., Pentecost, B. T. and Spink, D. C. (1996) Effects of 2,3,7,8-tetrachlorodibenzo-ρ-dioxin, 12-O-tetradecanoylphorbol 13-acetate and 17α-estradiol on estrogen receptor regulation in MCF-7 human breast cancer cells. J. Cell. Biochem. 60, 173-184
97. 97 Sunahara, G. I., Guenat, C. and Grieu, F. (1989) Characterization of 3-methylcholanthrene effects on the rat glucocorticoid receptor in vivo. Cancer Res. 49, 3535-3541
98. 98 Lin, F. J., Stohs, S. J., Birnbaum, L. S., Clark, G., Luder, G. W. and Goldstein, J. A. (1991) The eflects of 2,3,7,8-tetrachlorodibenzo-ρ-dioxin (TCDD) on the hepatic estrogen and glucocorticoid receptors in congenic strains of Ah responsive and Ah nonresponsive C57BL/6J mice. Toxicol. Appl Pharmacol. 108, 129-139
99. 99 Lorick, K. L., Toscano, D. L. and Toscane, Jr., W. A. (1998) 2,3,7,8-tetrachlorodibenzo-ρ-dioxin alters retinoic acid receptor function in human keratinocytes. Biochem. Biophys Res. Commun. 243, 749-752
100. 100 Alexander, D. L., Ganem, L. G., Fernandez-Salguero, P., Gonzalez, F. and Jelcoate, C. R. (1998) Aryl hydrocarbon receptor is an inhibitory regulator of lipid synthesis and of commitment to adipogenesis. J. Cell Sci. 111, 3311-3322
101. 101 Sewall, C. H., Flagler, N., Vanden Heuvcel, J. P., Clark. G. C., Tritscher, A. M., Maronpot, R. M. and Lucier, G. W. (1995) Alterations in thyroid function in female Sprague-Dawley rats following chronic treatment with 2,3,7,8-tetrachlorodibenzo-ρ-dioxin. Toxicol. Appl. Pharmacol. 132, 237-244
102. 102 Emi, Y and Omura, T. (1988) Synthesis of sex-specitic forms of cytochrome P450 in rat liver is transiently suppressed by hepatic monooxygenase inducers. J. Biochem. (Tokyo) 104, 40-43
103. 103 Yeowell, H. N., Waxman, D. J., Wadhera, A. and Goldstein, J. A. (1987) Suppression of the constitutive, male-specific rat hepatic cytochrome P450 2c and its mRNA by 3,4,5,3′,4′.5′-hexachlorobiphenyl and 3-methylcholanthrene. Mol. Pharmacol. 32, 340-347
104. 104 Fernandez-Salguero, P. M., Pineau, T., Hilbert, D. M., McPhail, T., Lee, S. S., Kimura, S., Nebert, D. W., Rudikoff, S., Ward, J. M. and Gonzalez, F. J. (1995) Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 268, 722-726
105. 105 Roberts, E. S., Vaz, A. D. and Coon, M. J. (1992) Role of isozymes of rabbit microsomal cytochrome P450 in the metabolism of retinoic acid, retinol, and retinal. Mol. Pharmacol. 41, 427-433
106. 106 Raner, G. M., Vaz, A. D. and Coon, M. J. (1996) Metabolism of all-trans, 9-cis, and 13-cis isomers of retinal by purified isozymes of microsomal cytochrome P450 and mechanism-based inhibition of retinoid oxidation by citral. Mol. Pharmacol. 49, 515-522
107. 107 Liang, H. C., Li, H , McKinnon, R. A., Dulfy, J. J., Potter, S. S., Puga, A. and Nebert, D. W. (1996) Cyp1a2( - l - ) null mutant mice develop normally but show deficient drug metabolism. Proc. Natl. Acad. Sci. U.S.A. 93, 1671-1676
108. 108 Gonzalez, F. J. and Lee, Y.-H. (1996) Constitutive expression of hepatic cytochrome P450 genes. FASEB J. 10, 1112-1117
109. 109 Park, Y. and Kemper, B. (1996) The CYP2B1 proximal promoter contains a functional C/EBP regulatory element. DNA Cell Biol. 15, 693-701
110. 110 Corton, J. C., Fan, L. Q., Brown, S., Anderson, S. P., Bocos, C., Cattley, R. C. and Gustafsson, J.-Å. (1998) Down-regulation of cytochrome P450 2C family members and positive acute-phase response gene expression by peroxisome proliferator chemicals. Mol. Pharmacol. 54, 463-473
111. 111 Venepally, P., Chen, D. and Kemper, B. (1992) Transcriptional regulatory elements for basal expression of cytochrome P450IIC genes. J. Biol. Chem. 267, 17333-17338
112. 112 Fraser, J. D., Martinez, V., Straney, R. and Briggs, M. R. (1998) DNA binding and transcription activation specificity of hepatocyte nuclear factor 4. Nucleic Acids Res. 26, 2702-2706
113. 113 Chen, D., Lepar, G. and Kemper, B. (1994) A transcriptional regulatory element common to a large family of hepatic cytochrome P450 genes is a functional binding site of the orphan receptor HNF-4. J. Biol Chem. 269, 5420-5427
114. 114 Chen, D., Park, Y. and Kemper, B. (1994) Differential protein binding and transcriptional activities of HNF-4 elements in three closely related CYP2C genes. DNA Cell Biol. 13, 771-779
115. 115 Ibeanu, G. C. and Goldstein, J. A. (1995) Transcriptional regulation of human CYP2C genes: functional comparison of CYP2C9 and CYP2C18 promoter regions. Biochemistry 34, 8028-8036
116. 116 Yokomori, N , Nishio, K., Aida, K and Negishi, M (1997) Transcriptional regulation by HNF-4 of the steroid 15α-hydroxylase P450 (Cyp2a-4) gene in mouse liver. J. Steroid Biochem. Mol. Biol. 62, 307-314
117. 117 Huss, J. M. and Kasper, C. B. (1998) Nuclear receptor involvement in the regulation of rat P450 3A23 expression. J. Biol. Chem. 273, 16155-16162
118. 118 Ogino, M , Nagata, K., Miyata, M. and Yamazoe, Y. (1999) Hepalocyte nuclear factor 4-mediated activation of rat CYP3A1 gene and its modes of modulation by apolipoprotein Al regulatory protein I and v-ErbA-related protein 3. Arch. Biochem. Biophys. 362, 32-37
119. 119 Yoshioka, H., Lang, M., Wong, G. and Negishi, M. (1990) A specific cis-acting element regulates in vitro transcription of sex-dependent mouse steroid 16α-hydroxylase (C-P45016α) gene. J. Biol. Chem. 265, 14612-14617
120. 120 Legraverend, C., Eguchi, H., Ström, A., Lahuna, O., Mode, A., Tollet, P., Westin, S. and Gustafsson, J.-Å. (1994) Transactivation of the rat CYP2C13 gene promoter involves HNF-1, HNF-3, and members of the orphan receptor subfamily. Biochemistry 33, 9889-9897
121. 121 Ström, A., Westin, S., Eguchi, H., Gustafsson, J-Å. and Mode, A. (1995) Characterization of orphan nuclear receptor binding elements in sex-differentiated members of the CYP2C gene family expressed in rat liver. J. Biol. Chem. 270, 11276-11281
122. 122 Sueyoshi, T., Yokomori, N., Korach, K. S. and Negishi, M. (1999) Developmental action of estrogen receptor-α feminizes the growth hormone-Stat5b pathway and expression of Cyp2a4 and Cyp2d9 genes in mouse liver. Mol. Pharmacol. 56, 473-477
123. 123 Sundseth, S. S., Alberta, J. A. and Waxman, D. J. (1992) Sex-specific, growth hormone-regulated transcription of the cytochrome P450 2C11 and 2C12 genes. J. Biol. Chem. 267, 3907-3914
124. 124 Legraverend, C., Mode, A., Westin, S., Ström, A., Eguchi, H., Zaphiropoulos, P. G. and Gustafsson, J.-Å. (1992) Transcriptional regulation of rat P-450 2C gene subfamily members by the sexually dimorphic pattern of growth hormone secretion. Mol. Endocrinol. 6, 259-266
125. 125 Noshiro, M. and Negishi, M. (1986) Pretranslational regulation of sex-dependent testosterone hydroxylases by growth hormone in mouse liver. J. Biol. Chem. 261, 15923-15927
126. 126 Udy, G. B., Towers, R. P., Snell, R. G , Wilkins, R. J., Park, S.-H., Ram, P. A., Waxman, D. J. and Davey, H. W. (1997) Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. U.S.A. 94, 7239-7344
127. 127 Roselli, C. E. and Klosterman, S. A. (1998) Sexual differentation of aromatase activity in the rat brain: effects of perinatal steroid exposure. Endocrinology (Baltimore) 139, 3193-3201
128. 128 Fisher, C. R., Graves, K. H., Parlow, A. F. and Simpson, E. R. (1998) Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc. Natl. Acad. Sci. U.S.A. 95, 6965-6970
129. 129 Yang, C. S. and Lu, A. Y. H. (1988) The diversity of substrates for cytochrome P450. In Mammalian Cytochromes P450, vol. 2 (Guengerich, F. P., ed.), pp. 1-18, CRC Press, Boca Raton
130. 130 Honkakoski, P and Lang, M. A. (1989) The mouse liver phenobarbital-inducible P450 system. Arch. Biochem. Biophys. 273, 42-57
131. 131 Furster, C. and Wikvall, K. (1999) Identification of CYP3A4 as the major enzyme responsible for 25-hydroxylation of 5β-cholestane-3α,7α,12α-triol in human liver microsomes. Biochim. Biophys. Acta 1437, 46-52
132. 132 Omiecinski, C. J. (1986) Tissue-specific expression of rat mRNAs homologous to cytochromes P450b and P450e. Nucleic Acids Res. 14, 1525-1539
133. 133 Honkakoski, P., Kojo, A. and Lang, M. A. (1992) Regulation of mouse liver P450 2B subfamily by sex hormones and phenobarbital. Biochem. J. 285, 979-983
134. 134 Frueh, F. W., Zanger, U. M. and Meyer, U. A. (1997) Extent and character of pheno-barbital-induced changes in gene expression in the liver. Mol. Pharmacol. 51, 363-369
135. 135 Sidhu, J. S. and Omiecinski, C. J. (1998) Protein synthesis inhibitors exhibit a nonspecific effect on phenobarbital-inducible cytochrome P450 gene expression in primary rat hepatocytes. J. Biol. Chem. 273, 4769-4775
136. 136 Honkakoski, P. and Negishi, M. (1998) Protein serine/threonine phosphatase inhibitors suppress phenobarbital-induced Cyp2b10 gene transcription in mouse primary hepatocytes. Biochem. J. 330, 889-895
137. 137 Sidhu, J. S. and Omiecinski, C. J. (1997) An okadaic acid-sensitive pathway involved in the phenobarbital-mediated induction of CYP2B gene expression in primary rat hepatocyte cultures. J. Pharmacol Exp. Ther. 282, 1122-1129
138. 138 Honkakoski, P. and Negishi, M. (1998) Regulatory DNA elements of phenobarbital-responsive cytochrome P450 CYP2B genes. J. Biochem. Mol. Toxicol 12, 3-9
139. 139 Ramsden, R, Sommer, K. M. and Omiecinski, C. J. (1993) Phenobarbital induction and tissue-specific expression of the rat CYP2B2 gene in transgenic mice. J. Biol. Chem. 268, 21722-21726
140. 140 Hashimoto, T., Matsumoto, T., Nishizawa, M., Kawabata, S., Morohashi, K., Handa, S. and Omura, T. (1988) A mutant rat strain deficient in induction of a phenobarbital-inducible form of cytochrome P450 in liver microsomes. J. Biochem. (Tokyo) 103, 487-492
141. 141 Kende, A. S., Ebetino, F. H., Drendel, W. B., Sundaralingam, M., Glover, E. and Poland, A. (1985) Structure-activity relationship of bispyridyloxybenzene for induction of mouse hepatic aminopyrine N-demethylase activity. Mol. Pharmacol. 28, 445-453
142. 142 Trottier, E., Belzil, A., Stoltz, C. and Anderson, A. (1995) Localization of a phenobarbital-responsive element (PBRE) in the 5′-flanking region of the rat CYP2B2 gene. Gene 158, 263-268
143. 143 Park, Y., Li, H. and Kemper, B. (1996) Phenobarbital induction mediated by a distal CYP2B2 sequence in rat liver transiently transfected in situ. J. Biol. Chem. 271, 23725-23728
144. 144 Honkakoski, P. and Negishi, M. (1997) Characterization of a phenobarbital-responsive enhancer module in mouse P45G Cyp2b10 gene. J. Biol. Chem 272, 14943-14949
145. 145 Sueyoshi, T., Kawamoto, T., Zelko, I., Honkakoski, P. and Negishi, M. (1999) The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. J. Biol. Chem. 274, 6043-6046
146. 146 Kim, J. and Kemper, B. (1997) Phenobarbital alters protein binding to the CYP2BI/2 phenobarbital-responsive unit in native chromatin. J. Biol. Chem. 272, 29423-29435
147. 147 Honkakoski, P., Zelko, I., Sueyoshi, T. and Negishi, M. (1998) The orphan nuclear receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol. Cell. Biol. 18, 5652-5658
148. 148 Honkakoski, P., Moore, R., Washburn, K. and Negishi, M. (1998) Activation by diverse xenochemicals of the 51-base pair phenobarbital-responsive enhancer module in the CYP2B10 gene Mol. Pharmacol 53, 597-601
149. 149 Ramsden, R., Beck, N. B., Sommer, K. M. and Omiecinski, C J. (1999) Phenobarbital responsiveness conferred by the 5′-flanking region of the rat CYP2B2 gene in transgenic mice. Gene 228, 169-179
150. 150 Baes, M., Gulick, T., Choi, H. S., Martinoli, M. G., Simha, D. and Moore, D. D. (1994) A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol. Cell. Biol. 14, 1544-1551
151. 151 Lehmann, J. M., McKee, D. D., Watson, M. A., Willson, T. M., Moore, T. and Kliewer, S. A. (1998) The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J. Clin. Invest. 102, 1016-1023
152. 152 Choi, H. S., Chung, M., Tzameli, I., Simha, D., Lee, Y. K., Seol, W. and Moore, D. D. (1997) Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR. J. Biol. Chem. 272, 23565-23571
153. 153 Honkakoski, P., Moore, R., Gynther, J. and Negishi, M. (1996) Characterization of phenobarbital-inducible mouse Cyp2b10 gene transcription in primary hepatocytes. J. Biol. Chem. 271, 9746-9753
154. 154 Forman, B. M., Tzameli, I., Choi, H. S., Chen, J., Simha, D., Seol, W., Evans, R. M. and Moore, D. D. (1998) Androstane metabolites bind to and deactivate the nuclear receptor CARβ. Nature (London) 395, 612-615
155. 155 Gower, D. B. and Ruparelia, B. A. (1993) Olfaction in humans with special reference to odorous 16-androstenes: their occurrence, perception and possible social, psychological and sexual impact. J. Endocrinol. 137, 167-187
156. 156 Kliewer, S. A., Lehmann, J. and Willson, T. M. (1999) Orphan nuclear receptors: shifting endocrinology into reverse. Science 284, 757-760
157. 157 Kocarek, T. A., Kraniak, J. M. and Reddy, A. B. (1998) Regulation of rat hepatic cytochrome P450 expression by sterol biosynthesis inhibition: inhibitors of squalene synthase are potent inducers of CYP2B expression in primary cultured rat hepatocytes and rat liver. Mol. Pharmacol. 54, 474-484
158. 158 Kawamoto, T., Sueyoshi, T., Zelko, I., Moore, R., Washburn, K. and Negishi, M. (1999) Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. Mol. Cell. Biol. 19, 6318-6322
159. 159 DeFranco, D B., Qi, M., Borror, K. C., Garabedian, M. J. and Brautigan, D. L. (1991) Protein phosphatase types 1 and/or 2A regulate nucleocytoplasmic shuttling of glucocorticoid receptors. Mol. Endocrinol. 5, 1215-1228
160. 160 Chang, T. K., Teixeira, J., Gil, G. and Waxman, D. J. (1993) The lithocholic acid 6β-hydroxylase cytochrome P-450, CYP 3A10, is an active catalyst of steroid hormone 6β-hydroxylation. Biochem. J. 291, 429-433
161. 161 Thummel, K. E. and Wilkinson, G. R. (1998) In vitro and in vivo drug interactions involving human CYP3A. Annu. Rev. Pharmacol. Toxicol. 38, 389-430
162. 162 Schuetz, J. D., Beach, D. L. and Guzellan, P. S. (1994) Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. Pharmacogenetics 4, 11-20
163. 163 Barwick, J. L., Quattrochi, L. C., Mills, A. S., Potenza, C., Tukey, R. H. and Guzelian, P. S. (1996) Trans-species gene transfer for analysis of glucocorticoid-inducible transcriptional activation of transiently expressed human CYP3A4 and rabbit CYP3A6 in primary cultures of adult rat and rabbit hepatocytes. Mol. Pharmacol. 50, 10-16
164. 164 Schuetz, E. G., Brimer, C. and Schuetz, J. D. (1998) Environmental xenobiotics and the anti-hormones cyproterone acetate and spironolactone use the nuclear hormone pregnenolone X receptor to activate the CYP3A23 hormone response element. Mol. Pharmacol. 54, 1113-1117
165. 165 Quattrochi, L. C., Mills, A. S., Barwick, J. L., Yockey, C. B. and Guzelian, P. S. (1995) A novel cis-acting element in a liver cytochrome P450 3A gene confers synergistic induction by glucocorticoids plus antiglucocorticoids. J. Biol. Chem. 270, 28917-28923
166. 166 Huss, J. M., Wang, S. I., Astrom, A., McQuiddy, P. and Kasper, C. B. (1996) Dexamethasone responsiveness of a major glucocorticoid-inducible CYP3A gene is mediated by elements unrelated to a glucocorticoid receptor binding motif. Proc. Natl. Acad. Sci. U.S.A. 93, 4665-4670
167. 167 Pascussi, J.-M., Jounaidi, Y., Drocourt, L., Domergue, J., Balabaud, C., Maurel, P. and Vilarem, M.-J. (1999) Evidence for the presence of a functional pregnane X receptor response element in the CYP3A7 gene promoter. Biochem. Biophys. Res. Commun. 260, 377-381
168. 168 Goodwin, B., Hodgson, E. and Liddle, C. (1999) The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. Mol. Pharmacol. 56, 1329-1339
169. 169 Blumberg, B., Sabbagh, W., Juguilon, H., Bolado, J., van Meter, C. M., Ong, E. S. and Evans, R. M. (1998) SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Dev. 12, 3195-3205
170. 170 Kliewer, S. A., Moore, J. T., Wade, L., Staudinger, J. L., Watson, M. A., Jones, S. A., McKee, D. D., Oliver, B. B., Willson, T. M., Zetterstrom, R. H , Perlmann, T. and Lehmann, J. M. (1998) An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 92, 73-82
171. 171 Bertilsson, G., Heidrich, J., Svensson, K., Åsman, M., Jendeberg, L., Sydow-Bäckman, M., Ohlsson, R., Postlind, H., Blomquist, P and Berkenstam, A. (1998) Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc. Natl. Acad. Sci. U.S.A. 95, 12208-12213
172. 172 Janowski, B. A., Grogan, M. J., Jones, S. A., Wisely, G. B., Kliewer, S. A., Corey, E. J. and Mangelsdorf, D. J. (1999) Structural requirements of ligands for the oxysterol liver X receptors LXRα and LXRβ. Proc. Natl. Acad. Sci. U.S.A. 96, 266-271
173. 173 Traber, P. G., Wang, W., McDonnell, M. and Gumucio, J. J. (1990) P450IIB gene expression in rat small intestine: cloning of intestinal CYPIIB1 mRNA using the polymerase chain reaction and transcriptional regulation of induction. Mol. Pharmacol. 37, 810-819
174. 174 Meehan, R. R., Forrester, L. M., Stevenson, K., Hastie, N. D., Buchmann, A., Kunz, H. W. and Wolf, C. R. (1988) Regulation of phenobarbital-inducible cytochrome P450s in rat and mouse liver following dexamethasone administration and hypophysectomy. Biochem. J. 254, 789-797
175. 175 Kocarek, T. A., Schuetz, E. G. and Guzelian, P. S. (1990) Differentiated induction of cytochrome P450b/e and P450p mRNAs by dose of phenobarbital in primary cultures of rat hepatocytes. Mol. Pharmacol. 38, 440-444
176. 176 Jaiswal, A. K., Haaparanta, T., Luc, P.-V., Schembri, J. and Adesnik, M. (1990) Glucocorticoid regulation of a phenobarbital-inducible P450 gene: the presence of a functional glucocorticoid response element in the 5′-flanking region of the CYP2B2 gene. Nucleic Acids Res. 18, 4237-4242
177. 177 Schuetz, J. D., Schuetz, E. G., Thottassery, J V., Guzelian, P. S., Strom, S. and Sun, D. (1996) Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells. Mol. Pharmacol. 49, 63-72
178. 178 Pereira, T. M., Carlstedt-Duke, J., Lechner, M. C. and Gustafson, J.-Å. (1998) Identification of a functional glucocorticoid response element in the CYP3A1/IGC2 gene. DNA Cell Biol. 17, 39-49
179. 179 Burger, H.-J., Schuetz, J. D., Schuetz, E. G. and Guzelian, P. S. (1992) Paradoxical transcriptional activation of rat liver cytochrome P450 3A1 by dexamethasone and the antiglucocorticoid pregnenolone 16α-carbonitrile: analysis by transient transfection into primary monolayer cultures of adult rat hepatocytes. Proc. Natl. Acad. Sci. U.S.A. 89, 2145-2149
180. 180 Zhang, H., LeCluyse, E., Liu, L., Hu, M., Matoney, L., Zhu, W. and Yan, B. (1999) Rat pregnane X receptor: molecular cloning, tissue distribution, and xenobiotic regulation. Arch. Biochem. Biophys. 368, 14-22
181. 181 Liddle, C., Goodwin, B. J., George, J., Tapner, M. and Farrell, G. C. (1998) Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone, and growth hormone in cultured hepatocytes. J. Clin. Endocrinol. Metab. 83, 2411-2416
182. 182 Ganem, L. G., Trottier, E., Anderson, A. and Jefcoate, C. R. (1999) Phenobarbital induction of CYP2B1/2 in primary hepatocytes: endocrine regulation and evidence for a single pathway for multiple inducers. Toxicol. Appl. Pharmacol. 155, 32-42
183. 183 Seol, W., Choi, H. S. and Moore, D. D. (1996) An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. Science 272, 1336-1339
184. 184 Johansson, L., Thomsen, J. S., Damdimopoulos, A. E., Sryrou, G., Gustafsson, J.-Å. and Treuter, E. (1999) The orphan nuclear receptor SHP inhibits agonist-dependent transcriptional activity of estrogen receptors ERα and ERβ. J. Biol. Chem. 274, 345-353
185. 185 Roman, L. J., Palmer, C. N. A., Clark, J. E., Muerhoff, A. S., Griffin, K. J., Johnson, E. F. and Masters, B. S. S. (1993) Expression of rabbit cytochromes P4504A which catalyze the ω-hydroxylalion of arachidonic acid, fatty acids, and prostaglandins. Arch. Biochem. Biophys. 307, 57-65
186. 186 Sharma, R., Lake, B. G. and Gibson, G. G. (1988) Co-induction of microsomal cytochrome P-452 and the peroxisomal fatty acid beta-oxidation pathway in the rat by clofibrate and di-(2-ethylhexyl)phthalate. Dose-response studies. Biochem. Pharmacol. 37, 1203-1206
187. 187 Issemann, I. and Green, S. (1990) Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature (London) 347, 645-650
188. 188 Gonzalez, F. J., Peters, J. M. and Cattley, R. C. (1998) Mechanism of action of the nongenotoxic peroxisome proliterators: role of the peroxisome proliferator-activator receptor α. J. Natl. Cancer Inst. 90, 1702-1709
189. 189 Varnecq, J. and Latruffe, N. (1999) Medical significance of peroxisome proliferator-activated receptors. Lancet 354, 141-148
190. 190 Johnson, E. F., Palmer, C. N. A, Griffin, K. J. and Hsu, M. H. (1996) Role of the peroxisome proliferator-activated receptor in cytochrome P450 4A gene regulation. FASEB J. 10, 1241-1248
191. 191 Aldridge, T. C., Tugwood, J. D. and Green, S. (1995) Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription. Biochem. J. 306, 473-479
192. 192 Palmer, C. N. A, Hsu, M. H., Griffin, H. J. and Johnson, E. F. (1995) Novel sequence determinants in peroxisome proliferator signaling. J. Biol. Chem. 270, 16114-16121
193. 193 Nakshatri, H. and Bhat-Nakshatri, P. (1998) Multiple parameters determine the specificity of transcriptional response by nuclear receptors HNF-4, ARP-1, PPAR, RAR and RXR through common response elements. Nucleic Acids Res. 26 2491-2499
194. 194 Castelein, H., Declercq, P. E. and Baes, M. (1997) DNA binding preferences of PPARα/RXRα heterodimers. Biochem. Biophys. Res. Commun. 233, 91-95
195. 195 Göttlicher, M, Widmark, E., Li, Q. and Gustafsson, J.-Å. (1992) Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc. Natl. Acad. Sci. U.S.A. 89, 4653-4657
196. 196 Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J. and Wahli, W. (1996) The PPARα-leukotriene B4 pathway to inflammation control. Nature (London) 384, 39-43
197. 197 Yu, K., Bayona, W., Kallen, C. B., Harding, H. P., Ravera, C. P., McMahon, G., Brown, M. and Lazar, M. A. (1995) Differential activation of peroxisome proliferator-activated receptors by eicosanoids J. Biol. Chem. 270, 23975-23983
198. 198 Forman, B. M., Chen, J. M. and Evans, R. M. (1997) Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ Proc. Natl. Acad. Sci. U.S.A. 94, 4312-4317
199. 199 Lehmann, J. M., Lenhard, J. M., Oliver, B. B., Ringold, G. M. and Kliewer, S. A. (1997) Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 272, 81-94
200. 200 Keller, H., Devchand, P. R., Perroud, M. and Wahli, W (1997) PPARα structure-function relationships derived from species-specific differences in responsiveness to hypolipidemic agents. Biol. Chem. 378, 651-655
201. 201 Maloney, E. K. and Waxman, D. J. (1999) Trans-activation of PPARα and PPARγ by structurally diverse environmental chemicals. Toxicol. Appl. Pharmacol. 161, 209-218
202. 202 Yan, Z. H., Karam., W. G., Staudinger, J. L., Medvedev, A., Ghanayem, B. I. and Jetten, A. M. (1998) Regulation of peroxisome proliferator-activated receptor α-induced transactivation by the nuclear orphan receptor TAK1/TR4. J. Biol. Chem. 273, 10948-10957
203. 203 Miyata, K. S., McCaw, S.E., Patel, H. V., Rachubinski, R. A. and Capone, J. P. (1996) The orphan nuclear hormone receptor LXRα interacts and inhibits peroxisome proliferator signaling. J. Biol. Chem. 271, 9189-9192
204. 3 signaling pathways. Proc. Natl. Acad. Sci. U.S.A. 92, 11593-11597
205. 205 Jow, L. and Mukherjee, R. (1995) The human peroxisome proliferator-activated receptor (PPAR) subtype NUC1 represses the activation of hPPARα and thyroid hormone receptors. J. Biol. Chem. 270, 3836-3840
206. 206 Webb, S. J., Xiao, G. H., Geoghegan, T. E and Prough, R. A. (1996) Regulation of CYP4A expression in rat by dehydroepiandrosterone and thyroid hormone. Mol. Pharmacol. 49, 276-287
207. 207 Lee, S. S., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P., Westphal, H. and Gonzalez, F. J. (1995) Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15, 3012-3022
208. 208 Peters, J. M., Zhou, Y. C., Ram, P. A., Lee, S. S., Gonzalez, F. J. and Waxman, D. J. (1996) Peroxisome proliferator-activated receptor α required for gene induction by dehydroepiandrosterone-3β-sulfate. Mol. Pharmacol. 50, 67-74
209. 209 Palmer, C. N. A., Hsu, M. H., Muerhoff, A. S., Griffin, K. J. and Johnson, E. F. (1994) Interaction of the peroxisome proliferator-activated receptor α with the retinoid X receptor α unmasks a cryptic peroxisome proliferator response element. J. Biol. Chem. 269, 18083-18089
210. 210 Chambon, P. (1996) A decade of molecular biology of retinoic acid receptors. FASEB J. 10, 940-954
211. 211 Leo, M. A. and Lieber, C. S. (1985) New pathway for retinol metabolism in liver microsomes. J. Biol. Chem. 260, 5228-5231
212. 212 Zhang, Q. Y., Raner, G., Ding, X., Dunbar, D., Coon, M. J. and Kaminsky, L. S. (1998) Characterization of the cytochrome P450 CYP2J4: expression in rat small intestine and role in retinoic acid biotransformation from retinal. Arch. Biochem. Biophys. 353, 257-264
213. 213 Blumberg, B., Bolado, J., Derguini, F., Craig, A. G., Moreno, T., Chakravarti, D., Heyman, R. A., Buck, J. and Evans, R. M. (1996) Novel retinoic acid receptor ligands in Xenopus embryos. Proc. Natl. Acad. Sci. U.S.A. 93, 4873-4878
214. 214 Pijnappel, W. W. M., Folkers, G. E., de Jonge, W. J., Verdegem, P. J. E., de Laat, S. W., Lugtenburg, J., Hendriks, H. F. J., van der Saag, P. T. and Durston, A. J. (1998) Metabolism to a response pathway selective retinoid ligand during axial pattern formation. Proc. Natl. Acad. Sci. U.S.A. 95, 15424-15429
215. 215 White, J. A., Beckett-Jones, B., Quo, Y.-D., Dilworth, F. J., Bonasoro, J., Jones, G. and Petkovich, M. (1997) Identification of the retinoic acid-inducible all-trans-retinoic acid 4-hydroxylase. J. Biol. Chem. 272, 18538-18541
216. 216 Ray, W. J., Bain, G., Yao, M. and Gottlieb, D. I. (1997) CYP26, a novel mammalian cytochrome P450, is induced by retinoic acid and defines a new family. J. Biol. Chem. 272, 18702-18708
217. 217 Abu-Abed, S. S., Beckett, B. R., Chiba, H., Chithalen, J. V., Jones, G., Metzger, D., Chambon, P. and Petkovich, M. (1998) Mouse P450RAI (CYP26) expression and retinoic acid-inducible retinoic acid metabolism in F9 cells are regulated by retinoic acid receptor γ and and retinoid X receptor α. J. Biol. Chem. 273, 2409-2415
218. 218 Leo, M. A., Iida, S. and Lieber, C. S. (1984) Retinoic acid metabolism by a system reconstituted with cytochrome P450. Arch. Biochem. Biophys. 234, 305-312
219. 219 Leo, M. A., Lasker, J. M., Raucy, J. L., Kim, C. I., Black, M. and Lieber, C. S. (1989) Metabolism of retinol and retinoic acid by human liver cytochrome P450IIC8. Arch. Biochem. Biophys. 269, 305-312
220. 220 Westin, S., Mode, A., Murray, M., Chen, R. and Guslafsson, J.-Å. (1993) Growth hormone and vitamin A induce P4502C7 mRNA expression in primary rat hepatocytes. Mol. Pharmacol. 44, 997-1002
221. 221 Westin, S., Sonneveld, E., van der Leede, B. M., van der Saag, P. T., Gustafsson, J.-Å. and Mode, A. (1997) CYP2C7 expression in rat liver and hepatocytes: regulation by retinoids. Mol. Cell. Endocrinol. 129, 169-179
222. 3. Crit. Rev. Eukaryotic Gene Expression 8, 19-42
223. 223 Umesono, K., Murakami, K. K., Thompson, C. C. and Evans, R. M. (1991) Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D 3 receptors. Cell 65, 1255-1266
224. 224 vom Baur, E., Zechel, C., Heery, D., Heine, M. J. S., Garnier, J. M., Vivat, V., Le Douarin, B., Gronemeyer, H., Chambon, P. and Losson, R. (1996) Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J. 15, 110-124
225. 3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol. Cell. Biol. 15, 5789-5799
226. 3. Interplay with retinoid and thyroid hormone signalling. Eur. J. Biochem. 231, 517-527
227. 3. Mol. Pharmacol. 51, 741-754
228. 228 Cali, J. J. and Russell, D. W. (1991) Characterization of human sterol 27-hydroxylase, a mitochondrial P450 that catalyzes multiple oxidation reactions in bile acid biosynthesis. J. Biol. Chem. 266, 7774-7778
229. 3. Proc. Natl. Acad. Sci. U.S.A. 91, 10014-10018
230. 230 Rosen, H., Reshef, A., Maeda, N., Lippoldl, A., Shpizen, S., Triger, L., Eggertsen, G., Björkhem, I. and Leitersdorf, E. (1998) Markedly reduced bile acid synthesis but maintained levels of cholesterol and vitamin D metabolites in mice with disrupted sterol 27-hydroxylase gene. J. Biol. Chem. 273, 14805-14812
231. 3 25-hydroxylase. Biochem. Biophys. Res. Commun. 241, 491-497
232. 3 in rats. Arch. Biochem. Biophys 355, 77-83
233. 3 1α-hydroxylase and vitamin D synthesis. Science 277, 1827-1830
234. 3 1α-hydroxylase gene promoter. Proc. Natl. Acad. Sci. U.S.A. 95, 1387-1391
235. 3 1α-hydroxylase gene. Proc. Natl. Acad. Sci. U.S.A. 96, 6988-6993
236. 3. Biochem. Biophys. Res. Commun. 249, 11-16
237. 3. J. Biol. Chem. 266, 8690-8695
238. 3 24-hydroxylase, a multicatalytic enzyme. Biochemistry 35, 8465-8472
239. 239 St. Arnaud, R. (1999) Targeted inactivation of vitamin D hydroxylases in mice. Bone 25, 127-129
240. 3 24-hydroxylase gene. J. Biol. Chem. 269, 10545-10550
241. 3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements. Biochim. Biophys. Acta 1263, 1-9
242. 3 J. Biol. Chem. 272, 19027-19034
243. 3 and direct repeat 4 thyroid hormone signaling pathways by the human TR4 orphan receptor. J. Biol. Chem. 274, 16198-16205
244. 244 Hanukoglu, I. (1992) Steroidogenic enzymes: structure, function, and role in regulation of steroid hormone biosynthesis. J. Steroid Biochem. Mol. Biol. 43, 779-804
245. 245 Stromstedt, M. and Waterman, M. R. (1995) Messenger RNAs encoding steroido-genic enzymes are expressed in rodent brain. Brain Res. Mol. Brain Res. 34, 75-88
246. 246 Keeney, D. S., Ikeda, Y., Waterman, M. R. and Parker, K. L. (1995) Cholesterol sidechain cleavage cytochrome P450 gene expression in the primitive gut of the mouse embryo does not require steroidogenic factor 1. Mol. Endocrinol. 9, 1091-1098
247. 247 Lala, D. S., Ikeda, Y., Luo, X., Baity, L. A., Meade, J. C. and Parker, K. L. (1995) A cell-specific nuclear receptor regulates the steroid hydroxylases. Steroids 60, 10-14
248. 248 Honda, S., Morohashi, K., Nomura, M., Takeya, H., Kitayama, M. and Omura, T. (1993) Ad4BP regulating steroidogenic P-450 gene is a member of steroid hormone receptor superfamily. J. Biol. Chem. 268, 7494-7502
249. 249 Morohashi, K., Honda, S., Inomata, Y., Handa, H. and Omura, T. (1992) A common tens-acting factor, Ad4-binding protein, to the promoters of steroidogenic P450s. J. Biol. Chem 267, 17913-17919
250. 250 Honda, S., Morohashi, K. and Omura, T. (1990) Novel cAMP regulatory elements in the promoter region of bovine P-450(11γ) gene. J. Biochem. (Tokyo) 108, 1042-1049
251. 251 Lynch, J. P., Lala, D. S., Peluso, J. J., Luo, W., Parker, K. L. and White, B. L. (1993) Steroidogenic factor 1, an orphan receptor, regulates the expression of the rat aromatase gene in gonadal tissues. Mol. Endocrinol 7, 776-786
252. 252 Bakke, M and Lund, J. (1995) Mutually exclusive interactions of two nuclear orphan receptors determine activity of a cyclic adenosine 3′,5′-monophosphate-responsive sequence in the bovine CYP17 gene. Mol. Endocrinol. 9, 327-339
253. 253 Liu, Z. and Simpson, E. R. (1997) Steroidogenic factor 1 (SF-1) and Sp1 are required for regulation of bovine CYP11A gene expression in bovine luteal and adrenal Y1 cells. Mol. Endocrinol. 11, 127-137
254. 254 Chau, Y. M., Crawford, P. A., Woodson, K. G., Polish, J. A., Olson, L. M. and Sadovsky, Y. (1997) Role of steroidogenic factor 1 in basal and 3′,5′-cyclic adenosine monophosphate-mediated regulation of cytochrome P450 side-chain cleavage enzyme in the mouse. Biol. Reprod. 57, 765-771
255. 255 Luo, X., Ikeda, Y. and Parker, K. L. (1994) A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 77, 481-490
256. 256 Lala, D. S., Syka, P. M., Lazarchik, S. B., Mangelsdorf, D. J., Parker, K. L. and Heyman, R. A. (1995) Activation of the orphan nuclear receptor steroidogenic factor 1 by oxysterols. Proc. Natl. Acad. Sci. U.S.A. 94, 4895-4900
257. 257 Mellon, S. H. and Bair, S. R. (1998) 25-hydroxycholesterol is not a ligand for the orphan nuclear receptor steroidogenic factor-1 (SF-1). Endocrinology (Baltimore) 139, 3026-3029
258. 258 Christenson, L. K., McAllister, J. M., Martin, K. O., Javitt, N. B., Osborne, T. F. and Strauss, J. F. (1998) Oxysterol regulation of steroidogenic acute regulatory protein gene expression. Structural specificity and transcriptional and posttranscriptional actions. J. Biol. Chem. 273, 30729-30735
259. 259 Jacob, A. L. and Lund, J. (1998) Mutations in the activation function-2 core domain of steroidogenic factor-1 dominantly suppresses PKA-dependent transactivation of the bovine CKP17 gene. J. Biol. Chem 273, 13391-13394
260. 260 Liu, Z. and Simpson, E. R. (1999) Molecular mechanism for cooperation between Sp1 and steroidogenic factor-1 (SF-1) to regulate bovine CYP11A gene expression. Mol. Cell. Endocrinol. 153, 183-196
261. 261 Sadovsky, Y., Crawford, P. A., Woodson, K. G., Polish, J. A., Clements, M. A., Tourtellotte, L M., Simburger, K. and Milbrandt, J. (1995) Mice deficient in the orphan receptor steroidogenic factor 1 lack adrenal glands and gonads but express P450 side-chain cleavage enzyme in the placenta and have normal embryonic serum levels of corticosteroids. Proc. Natl. Acad Sci. U.S.A 92, 10939-10943
262. 262 Zhang, P. and Mellon, S. H. (1997) Multiple orphan nuclear receptors converge to regulate rat P450c17 gene transcription: novel mechanisms for orphan nuclear receptor action. Mol. Endocrinol. 11, 891-904
263. 263 Yang, C., Zhou, C. and Chen, S. (1998) Modulation of aromatase expression in the breast tissue by ERRα1 orphan receptor. Cancer Res. 58, 5695-5700
264. 264 Zhang, P., Hammer, F., Bair, S., Wang, J., Reeves, W. H. and Mellon, S. H. (1999) Ku autoimmune antigen is involved in placental regulation of rat P450c17 gene transcription. DNA Cell Biol. 18, 197-208
265. 265 Mukai, K, Mitani, F., Shimada, H. and Ishimura, Y. (1995) Involvement of an AP-1 complex in zone-specific expression of the CYP11B1 gene in the rat adrenal cortex. Mol. Cell. Biol. 15, 6003-6012
266. 266 Waterman, M. R. and Bischof, L. J (1996) Mechanisms of ACTH (cAMP)-dependent transcription of adrenal steroid hydroxylases. Endocr. Res. 22, 615-620
267. 267 Michael, M. D., Kilgore, M. W., Morohashi, K. and Simpson, E. R. (1995) Ad4BP/SF-1 regulates cyclic AMP-induced transcription from the proximal promoter (PII) of the human aromatase P450 (CYP19) gene in the ovary. J. Biol. Chem. 270, 13561-13566
268. 268 Carlone, D. L. and Richards, J. S. (1997) Functional interactions, phosphorylation, and levels of 3′,5′-cyclic adenosine monophosphate-regulatory element binding protein and steroidogenic factor-1 mediate hormone-regulated and constitutive expression of aromatase in gonadal cells. Mol. Endocrinol. 11, 292-304
269. 269 Ahlgren, R., Suske, G., Waterman, M. R. and Lund, J. (1999) Role of Sp1 in cAMP-dependent transcriptional regulation of the bovine CYP11A gene. J. Biol. Chem. 274, 19422-19428
270. 270 Kagawa, N. and Waterman, M. R. (1992) Purification and characterization of a transcription factor which appears to regulate cAMP responsiveness of the human CYP21B gene. J. Biol. Chem. 267, 25213-25219
271. 271 Nomura, M., Kawabe, K., Matsushita, S., Oka, S., Hatano, O., Harada, N., Nawata, H. and Morohashi, K. (1998) Adrenocortical and gonadal expression of the mammalian Ftz-F1 gene encoding Ad4BP/SF-1 is independent of pituitary control. J. Biochem. (Tokyo) 124, 217-224
272. 272 Brown, M. S. and Goldstein, J. L. (1997) The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89, 331-340
273. 273 Rozman, D., Stromstedt, M., Tsui, L. C., Scherer, S. W. and Waterman, M. R. (1996) Structure and mapping of the human lanosterol 14α-demethylase gene (CYP51) encoding the cytochrome P450 involved in cholesterol biosynthesis: comparison of exon/intron organization with other mammalian and fungal CYP genes. Genomics 38, 371-381
274. 274 Stromstedt, M., Waterman, M. R., Haugen, T. B., Tasken, K., Parvinen, M. and Rozman, D. (1998) Elevated expression of lanosterol 14α-demethylase (CYP51) and the synthesis of oocyte meiosis-activating sterols in postmeiotic germ cells of male rats. Endocrinology (Baltimore) 139, 2314-2321
275. 275 Janowski, B. A., Willy, P. J., Devi, T. R., Falck, J R. and Mangelsdorf, D. J. (1996) An oxysterol signalling pathway mediated by the nuclear receptor LXR α. Nature (London) 383, 728-731
276. 276 Stromstedt, M., Rozman, D. and Waterman, M. R. (1996) The ubiquitously expressed human CYP51 encodes lanosterol 14α-demethylase, a cytochrome P450 whose expression is regulated by oxysterols. Arch. Biochem. Biophys. 329, 73-81
277. 277 Yoshida, Y., Yamashita, C., Noshiro, M., Fukuda, M. and Aoyama, Y. (1996) Sterol 14-demethylase P450 activity expressed in rat gonads: contribution to the formation of mammalian meiosis-activating sterol. Biochem. Biophys. Res. Commun. 223, 534-538
278. 278 Russell, D. W. and Setchell, K. D. R. (1992) Bile acid biosynthesis. Biochemistry 31, 4737-4749
279. 279 Noshiro, M., Nishimoto, M., Morohashi, K. and Okuda, K. (1989) Molecular cloning of cDNA for cholesterol 7α-hydroxylase from rat liver microsomes. Nucleotide sequence and expression. FEBS Lett. 257, 97-100
280. 280 Russell, D. W. (1999) Nuclear orphan receptors control cholesterol catabolism. Cell 97, 539-542
281. 281 Rose, K. A., Stapleton, G., Dott, K., Kieny, M. P., Best, R., Schwarz, M., Russell, D W., Björkhem, I., Seckl, J. and Lathe, R. (1997) Cyp7b, a novel brain cytochrome P450, catalyzes the synthesis of neurosteroids 7α-hydroxydehydroepiandrosterone and 7α-hydroxypregnenolone. Proc. Natl. Acad. Sci. U.S.A. 94, 4925-4930
282. 282 Schwarz, M., Lund, E. G., Lathe, R., Björkhem, I. and Russell, D. W. (1997) Identilication and characterization of a mouse oxysterol 7α-hydroxylase cDNA. J. Biol. Chem. 272, 23995-24001
283. 283 Lund, E. G., Guileyardo, J. M. and Russell, D. W. (1999) cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc. Natl. Acad. Sci. U.S.A. 96, 7238-7243
284. 284 Lund, E. G., Kerr, T. A., Sakai, J., Li, W.-P. and Russell, D. W. (1998) cDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism. J. Biol. Chem. 273, 34316-34318
285. 285 Lehmann, J. M., Kliewer, S. A., Moore, L. B., Smith-Oliver, T. A., Oliver, B. B., Su, J.-L., Sundseth, S. S., Winegar, D A., Blanchard, D. E., Spencer, T. A. and Willson, T M. (1997) Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem. 272, 3137-3140
286. 286 Stroup, D., Crestani, M. and Chiang, J. Y. L. (1997) Identification of a bile acid response element in the cholesterol 7α-hydroxylase gene CYP7A. Am. J. Physiol. 273, G508-G517
287. 287 Peet, D. J., Turley, S.D., Ma, W., Janowski, B. A., Lobaccaro, J.-M. A., Hammer, R. E. and Mangelsdorf, D. J. (1998) Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR α. Cell 93, 693-704
288. 288 Nitta, M., Ku, S., Brown, C., Okamoto, A. Y. and Shan, B. (1999) CPF: An orphan nuclear receptor that regulates liver-specific expression of the human cholesterol 7α-hydroxylase gene. Proc. Natl. Acad. Sci. U.S.A. 96, 6660-6665
289. 289 Wang. H., Chen, J., Hollister, K., Sowers. L. C. and Forman, B. M. (1999) Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol. Cell 3, 543-553
290. 290 Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D. and Lehmann, J. M. (1999) Bile acids: natural ligands for an orphan nuclear receptor. Science 284, 1365-1368
291. 291 Forman, B. M., Goode, E., Chen, J., Oro, A. E., Bradley, D. J., Perlmann, T., Noonan, D. J., Burka, L. T., McMorris, T., Kozak, C. A., Lamph, W. W., Evans, R. M. and Weinberger, C. (1995) Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 81, 687-693
292. 292 Makishima, M., Okamoto, A. Y , Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J. and Shan, B. (1999) Identification of a nuclear receptor for bile acids. Science 284, 1362-1365
293. 293 Stroup, D., Crestani, M. and Chiang, J. Y. L. (1997) Orphan receptors chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) and retinoid X receptor (RXR) activate and bind the rat cholesterol 7α-hydroxylase gene (CYP7A). J. Biol. Chem. 272, 9833-9839
294. 294 Pikuleva, I. A., Babiker, A., Waterman, M. R. and Björkhem, I. (1998) Activities of recombinant human cytochrome P450c27 (CYP27) which produce intermediates of alternative bile acid biosynthetic pathways. J. Biol. Chem. 273, 18153-18160
295. 295 Xu, G., Salen, G., Shefer, S., Tint, G S., Nguyen, L. B., Chen, T. S. and Greenblatt, D. (1999) Increasing dietary cholesterol induces different regulation of classic and alternative bile acid synthesis. J. Clin. Invest. 103, 89-95
296. 296 Twisk, J., de Wit, E. C. and Princen, H. M. (1995) Suppression of sterol 27-hydroxylase mRNA and transcriptional activity by bile acids in cultured rat hepatocytes. Biochem. J. 305, 505-511
297. 297 Stravitz, R. T., Vlahcevic, Z. R., Russell, T. L., Heizer, M. L., Avadhani, N. G. and Hylemon, P. B. (1996) Regulation of sterol 27-hydroxylase and an alternative pathway of bile acid biosynthesis in primary cultures of rat hepatocytes. J. Steroid Biochem. Mol. Biol. 57, 337-347
298. 298 Björkhem, I., Diczfalusy, U. and Lutjohann, D. (1999) Removal of cholesterol from extrahepatic sources by oxidative mechanisms. Curr. Opin. Lipidol. 10, 161-165
299. 299 Andersson, U., Yang, Y.-Z., Björkhern, I., Einarsson, C., Eggertsen, G. and Gåfvels, M. (1999) Thyroid hormone suppresses hepatic sterol 12α-hydroxylase (CYP8B1) activity and messenger ribonucleic acid in rat liver: failure to define known thyroid response elements in the gene. Biochim. Biophys. Acta 1438, 167-184
300. 300 Ishida, H., Kuruta, Y., Gotoh, O., Yamashita, C., Yoshida, Y. and Noshiro, M. (1999) Structure, evolution, and liver-specific expression of sterol 12α-hydroxylase P450 (CYP8B). J. Biochem. (Tokyo) 126, 19-25
301. 301 Li, H. C., Dehai, S. S. and Kupfer, D. (1995) Induction of the hepatic CYP2B and CYP3A enzymes by the proestrogenic pesticide methoxychlor and by DDT in the rat. Effects on methoxychlor metabolism. J. Biochem. Toxicol. 10, 51-61
302. 302 Honkakoski, P. and Negishi, M. (1997) The structure, function, and regulation of cytochrome P450 2A enzymes. Drug Metab. Rev. 29, 977-996
303. 303 Stresser, D. M. and Kupfer, D. (1998) Human cytochrome P450-catalyzed conversion of the proestrogenic pesticide methoxychlor into an estrogen. Role of CYP2C19 and CYP1A2 in O-demethylation. Drug. Metab. Dispos. 26, 868-874